Vidofludimus calcium for the treatment of multiple sclerosis: development rationale, mechanism of action, and early trial data

Matej Ondrus, Robert J. Fox, Evelyn Peelen, Juliano Fonseca, Valentina Sciacca, Ines Sanchez-Gomez, Jacques Arend, Alexandra Herrmann, Maria Samcova, Christian Gege, Lesia Havrylova, Hella Kohlhof, Jason Tardio, Daniel Vitt, Andreas Muehler

Expert Opinion on Investigational Drugs
Published: July 16, 2026

https://doi.org/10.1080/13543784.2026.2705509